Concepedia

Publication | Closed Access

Therapeutic efficacy and safety of oral propafenone for atrial fibrillation

DOI

63

Citations

8

References

1989

Year

James G. Porterfield, Linda M. Porterfield
The American Journal of Cardiology

References

YearCitations

Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac Preparations

F. Ledda, Laura Mantelli, Stefano Manzini,

Journal of Cardiovascular Pharmacology

1981

127

Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia

Stuart J. Connolly, Robert E. Kates, Cynthia Lebsack,

The American Journal of Cardiology

1983

85

Propafenone: A new agent for ventricular arrhythmia

Philip J. Podrid, Bernard Lown

Journal of the American College of Cardiology

1984

76

Propafenone for paroxysmal atrial fibrillation

Stephen C. Hammill, Douglas L. Wood, Bernard J. Gersh,

The American Journal of Cardiology

1988

66

Propafenone for prevention of recurrent atrial fibrillation

Charles R. Kerr, George J. Klein, James E. Axelson,

The American Journal of Cardiology

1988

62

Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia

Stephen C. Hammill, Christopher J. McLaran, Douglas L. Wood,

Journal of the American College of Cardiology

1987

51

Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia

M Manz, Gerhard Steinbeck, Berndt Lüderitz

The American Journal of Cardiology

1985

36

Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: A 2-year experience

Ha Dinh, Bonnie J. Baker, Neil de Soyza,

American Heart Journal

1988

16

Page 1